31 results
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
4 Mar 24
Entry into a Material Definitive Agreement
5:22pm
or from transferring any property or assets to the Company or to any other subsidiary.
(kk) Anti-Corruption and Anti-Bribery Laws. Neither the Company … (the “FCPA”), the UK Bribery Act 2010, or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, authorized, requested
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
31 Jan 24
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
9:00am
or from transferring any property or assets to the Company or to any other subsidiary.
(jj) Anti-Corruption and Anti-Bribery Laws. Neither the Company … (the “FCPA”), the UK Bribery Act 2010, or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, authorized, requested
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
12 Oct 23
Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering
5:04pm
transferring any property or assets to the Company or to any other subsidiary.
(jj) Anti-Corruption and Anti-Bribery Laws. Neither the Company nor … (the “FCPA”), the UK Bribery Act 2010, or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, authorized, requested, or taken
8-K
EX-1.1
aa0ns b87ydw
15 Dec 22
Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
5:18pm
8-K
EX-1.1
7qb0mmm4f5m x1
30 Jun 21
Entry into a Material Definitive Agreement
4:25pm
8-K
EX-2.1
4cpys
29 Jan 21
Entry into a Material Definitive Agreement
8:05am
8-K
EX-10.1
9y68 stamclrqsrx
29 Jan 21
Entry into a Material Definitive Agreement
8:05am